Sort by

Send to

Choose Destination

Links from PubMed

Items: 15


Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE.

Arch Womens Ment Health. 2013 Apr;16(2):149-57. doi: 10.1007/s00737-013-0330-6.


Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.

Macfadden W, DeSouza C, Crivera C, Kozma CM, Dirani RD, Mao L, Rodriguez SC.

BMC Psychiatry. 2011 Oct 14;11:167. doi: 10.1186/1471-244X-11-167.


Clinical potential of lurasidone in the management of schizophrenia.

Samalin L, Garnier M, Llorca PM.

Ther Clin Risk Manag. 2011;7:239-50. doi: 10.2147/TCRM.S12701.


Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.

Liu-Seifert H, Ascher-Svanum H, Osuntokun O, Jen KY, Gomez JC.

BMC Psychiatry. 2011 May 17;11:87. doi: 10.1186/1471-244X-11-87.


Factors affecting treatment discontinuation and treatment outcome in patients with schizophrenia in Korea: 10-year follow-up study.

Jung SH, Kim WH, Choi HJ, Kang MH, Lee JS, Bae JN, Kim CE.

Psychiatry Investig. 2011 Mar;8(1):22-9. doi: 10.4306/pi.2011.8.1.22.


Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.

Ascher-Svanum H, Zhu B, Faries DE, Lacro JP, Dolder CR, Peng X.

Patient Prefer Adherence. 2008 Feb 2;2:67-77.


Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States.

Furiak NM, Ascher-Svanum H, Klein RW, Smolen LJ, Lawson AH, Conley RR, Culler SD.

Cost Eff Resour Alloc. 2009 Apr 7;7:4. doi: 10.1186/1478-7547-7-4.


Clinical trial design: horses for courses.

Geddes JR.

World Psychiatry. 2009 Feb;8(1):28-9. No abstract available.


Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.

Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB.

Schizophr Bull. 2006 Oct;32(4):715-23.


Modern antipsychotic drugs: a critical overview.

Gardner DM, Baldessarini RJ, Waraich P.

CMAJ. 2005 Jun 21;172(13):1703-11. Review.


Assessing harmful effects in systematic reviews.

McIntosh HM, Woolacott NF, Bagnall AM.

BMC Med Res Methodol. 2004 Jul 19;4:19.

Items per page

Supplemental Content

Support Center